Paper
0
35 The impact of treatment modalities on use of ctDNA as an early endpoint in aNSCLC trials
Authors
Hillary Andrews,Névine Zariffa
Katherine Nishimura,Emily Goren,Yu Deng,Megan Eisele,Joe Ensor,David Fabrizio,Carin Espenschied,Vincent Haddad,Minetta Liu,Brittany McKelvey,Dimple Modi,Achim Moesta,Katie Quinn,Adam Rosenthal,Diana Vega,Wei Zou,Antje Hoering,Mark Stewart,Jeff Allen,Hillary Stires
+20 authors
,Diana MerinoPublished
Nov 1, 2024
Show more
Save
Tip0
TipSave